Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

Disrupting any of the three systems that contribute to epigenetic alterations can cause abnormal activation or silencing of genes. Such disruptions have been associated with cancer, syndromes ...

A newly published review in Genes & Diseases explores the oncogenic activation of PIK3CA in cancer and highlights emerging ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes. Conducted by ...

Ignite Proteomics offers the only commercially available and clinically validated assay that measures both the expression and activation levels of drug targets in breast tumors. This innovative ...